世界の静脈内免疫グロブリン療法市場予測（～2024年）

• 英文タイトル：Global Intravenous Immune Globulin Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D4057
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、124ページ
• 納品方法：Eメール
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、静脈内免疫グロブリン療法の世界市場について調べ、まとめました。種類別セグメントは、液状、凍結乾燥粉末状等、用途別セグメントは、免疫不全症、自己免疫疾患、急性感染等に区分しました。静脈内免疫グロブリン療法の世界市場概観、企業動向、企業別静脈内免疫グロブリン療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・静脈内免疫グロブリン療法の市場概観
・静脈内免疫グロブリン療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・静脈内免疫グロブリン療法の企業別販売動向、市場シェア、市場集中度、競争動向
・静脈内免疫グロブリン療法の世界市場規模
・静脈内免疫グロブリン療法の北米市場分析（アメリカ、カナダ、メキシコ等）
・静脈内免疫グロブリン療法のアメリカ市場規模推移
・静脈内免疫グロブリン療法のカナダ市場規模推移
・静脈内免疫グロブリン療法のメキシコ市場規模推移
・静脈内免疫グロブリン療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・静脈内免疫グロブリン療法のドイツ市場規模推移
・静脈内免疫グロブリン療法のイギリス市場規模推移
・静脈内免疫グロブリン療法のロシア市場規模推移
・静脈内免疫グロブリン療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・静脈内免疫グロブリン療法の日本市場規模推移
・静脈内免疫グロブリン療法の中国市場規模推移
・静脈内免疫グロブリン療法の韓国市場規模推移
・静脈内免疫グロブリン療法のインド市場規模推移
・静脈内免疫グロブリン療法の東南アジア市場規模推移
・静脈内免疫グロブリン療法の南米市場分析（ブラジル、アルゼンチン等）
・静脈内免疫グロブリン療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・静脈内免疫グロブリン療法の種類別分析/販売量、売上、市場シェア（液状、凍結乾燥粉末状）
・静脈内免疫グロブリン療法の用途別分析/市場規模（免疫不全症、自己免疫疾患、急性感染）
・静脈内免疫グロブリン療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・静脈内免疫グロブリン療法の販売チャネル・代理店・貿易業者・ディーラー分析

Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.

Scope of the Report:
The global Intravenous Immune Globulin Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Intravenous Immune Globulin Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Intravenous Immune Globulin Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Intravenous Immune Globulin Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Liquid Form
Lyophilized Powder Form

Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection

レポート目次

Table of Contents

1 Intravenous Immune Globulin Therapies Market Overview
1.1 Product Overview and Scope of Intravenous Immune Globulin Therapies
1.2 Classification of Intravenous Immune Globulin Therapies by Types
1.2.1 Global Intravenous Immune Globulin Therapies Revenue Comparison by Types (2019-2024)
1.2.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Types in 2018
1.2.3 Liquid Form
1.2.4 Lyophilized Powder Form
1.3 Global Intravenous Immune Globulin Therapies Market by Application
1.3.1 Global Intravenous Immune Globulin Therapies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immune Globulin Therapies Market by Regions
1.4.1 Global Intravenous Immune Globulin Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Intravenous Immune Globulin Therapies Status and Prospect (2014-2024)
1.5 Global Market Size of Intravenous Immune Globulin Therapies (2014-2024)
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Intravenous Immune Globulin Therapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immune Globulin Therapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Plasma
2.3.1 Business Overview
2.3.2 Intravenous Immune Globulin Therapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Intravenous Immune Globulin Therapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Biotest
2.5.1 Business Overview
2.5.2 Intravenous Immune Globulin Therapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Kedrion
2.6.1 Business Overview
2.6.2 Intravenous Immune Globulin Therapies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Kamada
2.7.1 Business Overview
2.7.2 Intravenous Immune Globulin Therapies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.8 China Biologic Products Holdings
2.8.1 Business Overview
2.8.2 Intravenous Immune Globulin Therapies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hualan Biological Engineering
2.9.1 Business Overview
2.9.2 Intravenous Immune Globulin Therapies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sichuan Yuanda Shuyang Pharmaceutical
2.10.1 Business Overview
2.10.2 Intravenous Immune Globulin Therapies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Intravenous Immune Globulin Therapies Market Competition, by Players
3.1 Global Intravenous Immune Globulin Therapies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Intravenous Immune Globulin Therapies Players Market Share
3.2.2 Top 10 Intravenous Immune Globulin Therapies Players Market Share
3.3 Market Competition Trend
4 Global Intravenous Immune Globulin Therapies Market Size by Regions
4.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Regions
4.2 North America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.3 Europe Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.5 South America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5 North America Intravenous Immune Globulin Therapies Revenue by Countries
5.1 North America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
5.2 USA Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5.3 Canada Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
5.4 Mexico Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6 Europe Intravenous Immune Globulin Therapies Revenue by Countries
6.1 Europe Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
6.2 Germany Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.3 UK Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.4 France Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.5 Russia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
6.6 Italy Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries
7.1 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
7.2 China Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.3 Japan Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.4 Korea Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.5 India Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8 South America Intravenous Immune Globulin Therapies Revenue by Countries
8.1 South America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
8.2 Brazil Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8.3 Argentina Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
8.4 Colombia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Intravenous Immune Globulin Therapies by Countries
9.1 Middle East and Africa Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.3 UAE Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.4 Egypt Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
9.6 South Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
10 Global Intravenous Immune Globulin Therapies Market Segment by Type
10.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Type (2014-2019)
10.2 Global Intravenous Immune Globulin Therapies Market Forecast by Type (2019-2024)
10.3 Liquid Form Revenue Growth Rate (2014-2024)
10.4 Lyophilized Powder Form Revenue Growth Rate (2014-2024)
11 Global Intravenous Immune Globulin Therapies Market Segment by Application
11.1 Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2014-2019)
11.2 Intravenous Immune Globulin Therapies Market Forecast by Application (2019-2024)
11.3 Immunodeficiency Revenue Growth (2014-2019)
11.4 Autoimmune Disease Revenue Growth (2014-2019)
11.5 Acute Infection Revenue Growth (2014-2019)
12 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
12.1 Global Intravenous Immune Globulin Therapies Market Size Forecast (2019-2024)
12.2 Global Intravenous Immune Globulin Therapies Market Forecast by Regions (2019-2024)
12.3 North America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.4 Europe Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.6 South America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Intravenous Immune Globulin Therapies Picture
Table Product Specifications of Intravenous Immune Globulin Therapies
Table Global Intravenous Immune Globulin Therapies and Revenue (Million USD) Market Split by Product Type
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Types in 2018
Figure Liquid Form Picture
Figure Lyophilized Powder Form Picture
Table Global Intravenous Immune Globulin Therapies Revenue (Million USD) by Application (2014-2024)
Figure Intravenous Immune Globulin Therapies Revenue Market Share by Applications in 2018
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Table Global Market Intravenous Immune Globulin Therapies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (2014-2024)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Intravenous Immune Globulin Therapies Type and Applications
Table Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Intravenous Immune Globulin Therapies Type and Applications
Table Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Plasma Basic Information, Manufacturing Base and Competitors
Table CSL Plasma Intravenous Immune Globulin Therapies Type and Applications
Table CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Intravenous Immune Globulin Therapies Type and Applications
Table Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Intravenous Immune Globulin Therapies Type and Applications
Table Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Intravenous Immune Globulin Therapies Type and Applications
Table Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Kamada Basic Information, Manufacturing Base and Competitors
Table Kamada Intravenous Immune Globulin Therapies Type and Applications
Table Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table China Biologic Products Holdings Basic Information, Manufacturing Base and Competitors
Table China Biologic Products Holdings Intravenous Immune Globulin Therapies Type and Applications
Table China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table Hualan Biological Engineering Intravenous Immune Globulin Therapies Type and Applications
Table Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Type and Applications
Table Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Intravenous Immune Globulin Therapies Revenue (Million USD) by Players (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue Share by Players (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Players in 2017
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Players in 2018
Figure Global Top 5 Players Intravenous Immune Globulin Therapies Revenue Market Share in 2018
Figure Global Top 10 Players Intravenous Immune Globulin Therapies Revenue Market Share in 2018
Figure Global Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue (Million USD) by Regions (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Regions (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Regions in 2018
Figure North America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Europe Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure South America Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table North America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
Table North America Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure North America Intravenous Immune Globulin Therapies Revenue Market Share by Countries in 2018
Figure USA Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Canada Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Mexico Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table Europe Intravenous Immune Globulin Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure Europe Intravenous Immune Globulin Therapies Revenue Market Share by Countries in 2018
Figure Germany Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure UK Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure France Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Russia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Italy Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Intravenous Immune Globulin Therapies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Share by Countries in 2018
Figure China Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Japan Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Korea Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure India Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table South America Intravenous Immune Globulin Therapies Revenue by Countries (2014-2019)
Table South America Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure South America Intravenous Immune Globulin Therapies Revenue Market Share by Countries in 2018
Figure Brazil Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Argentina Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Colombia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Intravenous Immune Globulin Therapies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure UAE Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Egypt Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure Nigeria Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Figure South Africa Intravenous Immune Globulin Therapies Revenue and Growth Rate (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue (Million USD) by Type (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue Share by Type (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Type (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Type in 2019
Table Global Intravenous Immune Globulin Therapies Revenue Forecast by Type (2019-2024)
Figure Global Intravenous Immune Globulin Therapies Market Share Forecast by Type (2019-2024)
Figure Global Liquid Form Revenue Growth Rate (2014-2019)
Figure Global Lyophilized Powder Form Revenue Growth Rate (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue by Application (2014-2019)
Table Global Intravenous Immune Globulin Therapies Revenue Share by Application (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Application (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Share by Application in 2019
Table Global Intravenous Immune Globulin Therapies Revenue Forecast by Application (2019-2024)
Figure Global Intravenous Immune Globulin Therapies Market Share Forecast by Application (2019-2024)
Figure Global Immunodeficiency Revenue Growth Rate (2014-2019)
Figure Global Autoimmune Disease Revenue Growth Rate (2014-2019)
Figure Global Acute Infection Revenue Growth Rate (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Intravenous Immune Globulin Therapies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
Figure Europe Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
Figure South America Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

動物免疫グロブリン製品市場：世界及び中国市場分析・予測（～2024年）

Animal-derived Immune Globulin Products Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT0390 2019年10月1日 137Pages
「動物免疫グロブリン製品市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における動物免疫グロブリン製品市場について調査・分析したレポートで、動物免疫グロブリン製品の世界市場動向、市場規模、主要企業情報などが含まれています。動物免疫グロブリン製品のタイプ別には、IVIgリキッド、IV...

世界の重症筋無力症治療市場予測（～2024年）

Global Myasthenia Gravis Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4153 2019年9月18日 103Pages
本調査レポートは、重症筋無力症治療の世界市場について調べ、まとめました。種類別セグメントは、重症筋無力症、先天性筋無力症、一般化筋無力症、一過性筋無力症、その他等、用途別セグメントは、病院及び診療所、診断センター、学術研究機関等に区分しました。重症筋無力症治療の世界市場概観、企業動向、企業別重症筋無...

世界のがん治療用遺伝子治療市場予測（～2024年）

Global Gene Therapies for Cancer Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3986 2019年9月18日 117Pages
本調査レポートは、がん治療用遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入等、用途別セグメントは、病院、クリニック、その他等に区分しました。がん治療用遺伝子治療の世界市場概観、企業動向、企業別がん治療用遺伝子治療シェア、市場...

世界の血液療法市場予測（～2024年）

Global Hematology Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4011 2019年9月18日 122Pages
本調査レポートは、血液療法の世界市場について調べ、まとめました。種類別セグメントは、血液学機器、血液学消耗品等、用途別セグメントは、診断研究所、病院および診療所、学術機関、その他等に区分しました。血液療法の世界市場概観、企業動向、企業別血液療法シェア、市場規模推移、市場規模予測（2019年-2024...

世界のヘルペス後神経痛治療市場予測（～2024年）

Global Post Herpetic Neuralgia Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4213 2019年9月18日 122Pages
本調査レポートは、ヘルペス後神経痛治療の世界市場について調べ、まとめました。種類別セグメントは、薬物、パッチ、ステロイド注射剤等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。ヘルペス後神経痛治療の世界市場概観、企業動向、企業別ヘルペス後神経痛治療シェア、市場規模推移、市場...

世界の静脈内（IV）液体バッグ市場予測（～2024年）

Global Intravenous (IV) Fluid Bags Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09D1849 2019年9月11日 115Pages
本調査レポートは、静脈内（IV）液体バッグの世界市場について調べ、まとめました。種類別セグメントは、PVC素材、非PVC素材等、用途別セグメントは、在宅医療、病院、その他医療センター等に区分しました。静脈内（IV）液体バッグの世界市場概観、メーカー動向、メーカー別静脈内（IV）液体バッグシェア、市場...

世界の血漿分画市場予測（～2024年）

Global Plasma Fractionation Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4204 2019年9月18日 123Pages
本調査レポートは、血漿分画の世界市場について調べ、まとめました。種類別セグメントは、アルブミン、免疫グロブリン、凝固因子等、用途別セグメントは、免疫学、血液学、その他等に区分しました。血漿分画の世界市場概観、企業動向、企業別血漿分画シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地...

静脈内（IV）ソリューション市場：世界及び中国市場分析・予測（～2024年）

Intravenous (IV) Solution Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT8312 2019年10月1日 140Pages
「静脈内（IV）ソリューション市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における静脈内（IV）ソリューション市場について調査・分析したレポートで、静脈内（IV）ソリューションの世界市場動向、市場規模、主要企業情報などが含まれています。
・静脈内（IV）ソリューショ...

静脈内ソリューション市場：世界及び中国市場分析・予測（～2024年）

Intravenous Solutions Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT3575 2019年10月8日 138Pages
「静脈内ソリューション市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における静脈内ソリューション市場について調査・分析したレポートで、静脈内ソリューションの世界市場動向、市場規模、主要企業情報などが含まれています。静脈内ソリューションのタイプ別には、全静脈栄養（TPN）、末梢静脈...

末梢静脈（IV）カテーテル市場：世界及び中国市場分析・予測（～2024年）

Peripheral Intravenous (IV) Catheter Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT4965 2019年10月8日 150Pages
「末梢静脈（IV）カテーテル市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における末梢静脈（IV）カテーテル市場について調査・分析したレポートで、末梢静脈（IV）カテーテルの世界市場動向、市場規模、主要企業情報などが含まれています。末梢静脈（IV）カテーテルのタイプ別には、短型P...

動物免疫グロブリン製品市場：世界及び中国市場分析・予測（～2024年） Animal-derived Immune Globulin Products Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Animal-derived Immune Globulin Products industry with a focus on the Chinese market. The report provides key statistics on the market stat…
世界の重症筋無力症治療市場予測（～2024年） Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs. Scope of the Report: The global Myasthenia Gravis Therapies market is valued at xx million USD …
世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
世界の血液療法市場予測（～2024年） Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood. Scope of the Report: The global Hematology Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR …
世界のヘルペス後神経痛治療市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antivi…